Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
1,2,2,14,15,16,19,20,21,35,36-undecahydroxy-3,6,11,24,32-pentaoxo-29-(3,4,5-trihydroxyphenylcarbonyloxy)-7,10,25,28,31,40-hexaoxaoctacyclo[35.2.1.05,39.08,27.09,30.012,17.018,23.033,38]tetraconta-4,12,14,16,18,20,22,33,35,37-decaene
ID: ALA1159466
PubChem CID: 46905122
Max Phase: Preclinical
Molecular Formula: C41H28O27
Molecular Weight: 952.65
Molecule Type: Small molecule
Associated Items: